GET DAILY SIGNALSGMR Solutions (GMRS) Holds Steady Near $11 with +3.7% Monthly Gain
Key Takeaways
- GMR Solutions is the nation's largest emergency medical services (EMS) provider, operating ground and air ambulance operations across roughly 1,400 U.S. counties.
- Shares moved about +3.7% over the trailing 30 days, holding a relatively narrow range around $11 per share after a choppy post-earnings reaction.
- Third-quarter 2026 revenue rose 5.9% to about $1.6 billion, while net income climbed 81.7% year over year to $135.6 million.
- Management narrowed full-year 2026 revenue guidance and lowered the top end of the range, citing unfavorable flying conditions and limited hurricane deployment activity.
- Elevated fuel costs and weather-related air transport cancellations remain the most visible near-term margin pressures.
- Balance-sheet progress continued, with net leverage reduced to 3.4x from 4.3x a year earlier and free cash flow improving to roughly $110 million.
- For deeper data on this ticker, explore Price Targets, Earnings, and Forecast pages to review additional analysis and metrics.
- Investors seeking automated, data-driven trading ideas can also explore Trending AI Robots for curated algorithmic strategies.
Current Market Snapshot for GMRS
GMRS shares have traded near the lower portion of their post-IPO range in recent weeks. The stock's most recent closing price of $10.99 sits roughly 3.7% above its level from about 30 days earlier, reflecting a market that has absorbed strong quarterly profit growth while weighing a softer revenue outlook and lingering cost pressures. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Following its third-quarter report, the stock sold off sharply in regular trading before paring losses in after-hours activity, a pattern that points to investor focus on guidance rather than the headline earnings beat. Broader healthcare-services sentiment has remained measured as reimbursement dynamics and inflation continue to shape expectations across the sector.
GMR Solutions (GMRS) Business Overview and Competitive Position
GMR Solutions operates as the largest provider of emergency medical services in the United States under the Global Medical Response brand. The company delivers emergent and non-emergent ground ambulance services, helicopter air ambulance transport, and mobile clinical services to roughly 5.5 million patients annually across markets representing more than 60% of the U.S. population.
The company's operating subsidiaries include American Medical Response (AMR), Air Evac Lifeteam, REACH Air Medical Services, Guardian Flight, Med-Trans Corporation, and AirMed International. This integrated air-and-ground platform is a key competitive advantage, allowing GMR to coordinate care across geographies and service lines while holding a leading position in the emergency air medical transport segment. Investors follow GMRS for its defensive demand profile, national scale, and deleveraging story following its 2026 initial public offering. From what I see, the scale here provides a meaningful edge in a fragmented market.
Recent Developments Driving GMRS
GMR Solutions reported third-quarter results in early November, with revenue increasing 5.9% year over year to about $1.6 billion and adjusted EBITDA rising 4.2% to roughly $357 million. Net income more than doubled to $135.6 million, supported by stronger operating performance and lower interest expense following debt reduction. Emergent ground transports grew 3.4%, while the company's 911 Nurse Navigation offering expanded call volume by about 51%.
At the same time, management narrowed full-year revenue guidance and lowered the top end to approximately $6.05 billion, citing less favorable flying conditions and minimal hurricane deployments. Maintenance, fuel, and other direct expenses rose 25.1% during the quarter, partly driven by higher fuel costs tied to geopolitical developments and the timing of aircraft maintenance events. I’m watching this closely with the help of Tickeron’s AI Pattern Search Engine to track similar cost patterns in the sector.
On the capital front, GMR completed a repricing of its first-lien term loan in September, reducing its interest margin by 50 basis points and repaying approximately $200 million of debt. In late October, the company announced an additional order of Bell 407GXi helicopters from Textron (TXT), continuing a fleet modernization program aimed at improving instrument-flight capability and reducing weather-related disruptions.
2026 Outlook and What Investors Should Watch
Looking ahead, investors will monitor whether GMR can sustain mid-single-digit revenue growth while defending margins against elevated fuel and wage inflation. Management has pointed to CPI-linked rate increases embedded in many contracts as a partial offset entering 2027, and expects favorable revenue estimate adjustments tied to No Surprises Act claims to trend lower over time.
Key items to watch include the pace of nurse navigation expansion and new-market contract wins, weather patterns affecting air transport capture rates, and ongoing reimbursement developments in Washington. Debt reduction remains a stated priority, with management targeting net leverage near 3.0x by the end of 2027. Regulatory scrutiny of emergency billing and private-equity ownership in healthcare also represents a longer-term factor for the company and the broader EMS industry.
Exploring Tickeron’s AI Trading Bots
In my analysis of GMRS, I turned to Tickeron’s AI Trading Bots to test a few rules-based strategies against the stock’s recent price action and volatility profile. These tools let me compare performance across different timeframes and market conditions without building everything from scratch. It’s a practical way to see how systematic approaches might align with the company’s defensive characteristics and deleveraging path.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
GMRS's RSI Indicator recovers from overbought zone
The 10-day RSI Indicator for GMRS moved out of overbought territory on November 09, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 1 instances where the indicator moved out of the overbought zone. In 1 of the 1 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 5 of 6 cases where GMRS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
GMRS moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GMRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
GMRS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on GMRS as a result. In 3 of 5 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for GMRS just turned positive on October 09, 2026. Looking at past instances where GMRS's MACD turned positive, the stock continued to rise in 2 of 2 cases over the following month. The odds of a continued upward trend are 90%.
The 10-day moving average for GMRS crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 1 of 1 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +9.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where GMRS advanced for three days, in 14 of 20 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 9 of 14 cases where GMRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.851) is normal, around the industry mean (204.532). P/E Ratio (-6.129) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.502) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. GMRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry HospitalNursingManagement
Advertisement